Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?

Introduction: Drug-induced liver injury (DILI) represents a serious medical challenge and a potentially fatal adverse event. Currently, DILI is a diagnosis of exclusion, and whilst the electronic evaluation of serious drug-induced hepatotoxicity (eDISH) have revolutionised the early assessment of DI...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Expert opinion on drug safety Jg. 15; H. 5; S. 625 - 634
Hauptverfasser:	Clarke, Joanna I., Dear, James W., Antoine, Daniel J.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Taylor & Francis 03.05.2016
Schlagworte:	Acetaminophen Acetaminophen - adverse effects Biomarkers - metabolism Chemical and Drug Induced Liver Injury - diagnosis Chemical and Drug Induced Liver Injury - etiology Chemical and Drug Induced Liver Injury - therapy DILI Drug-Related Side Effects and Adverse Reactions - diagnosis Drug-Related Side Effects and Adverse Reactions - physiopathology Humans idiosyncratic Prognosis qualification Sensitivity and Specificity qualification DILI Acetaminophen idiosyncratic
ISSN:	1474-0338, 1744-764X, 1744-764X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!